TK

Tushar Kanaiyalal Panot

Active Director Managing Director DIN 09518420
DIN 09518420 First appointment Feb 2022 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Tushar Kanaiyalal Panot

Data last updated:

Tushar Kanaiyalal Panot is a Managing Director at Kananta Pharma Private Limited (since 2022). The company operates in Trading.

DIN 09518420
Primary Designation Managing Director
Industry Trading
First Appointment 24 Feb 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kananta Pharma Private Limited U51909GJ2022PTC129629
Managing Director24 Feb 20222022Active

Board colleagues of Tushar Kanaiyalal Panot

NameDINCompanyDesignation
Kirtiben Kanaiyalal Panot09518421Kananta Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Kananta Pharma Private Limited
Premium access

Shareholding and investment profile for Tushar Kanaiyalal Panot

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tushar Kanaiyalal Panot

Tushar Kanaiyalal Panot currently holds 1 directorship: Kananta Pharma Private Limited (Managing Director, since 24 Feb 2022).

Tushar Kanaiyalal Panot was first appointed on 24 Feb 2022 as Managing Director at Kananta Pharma Private Limited.

The current boards of Tushar Kanaiyalal Panot's companies include Kirtiben Kanaiyalal Panot (Kananta Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available